ARTICLE | Clinical News
Balsalazide tablet regulatory update
January 5, 2009 8:00 AM UTC
Salix received a complete response letter from FDA for an NDA for balsalazide tablets to treat mild to moderate active ulcerative colitis in adult patients. Salix said FDA requested an additional clin...